Tarsus Pharmaceuticals
- Market cap
- 3.44B
- P/E (TTM)i
- -68.79
- P/Bi
- 9.93
- EPSi
- -1.59
- Div yieldi
- 0.00%
- 52W posi
- 52%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Tarsus Pharmaceuticals closed at 73.61, down 0.67%. Its market capitalisation is about 3.44B, the #2389 most valuable US-listed company we track. The 10 analysts covering the stock are, on balance, at Buy, targeting an average of 100.11 (+36%). Over the past year the stock has ranged from 53.89 to 91.53; it now sits 52% up that band.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 week.
- Recent price momentum is +6.0% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 13.1% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 74.11
- Open
- 73.58
- Day range
- 73.30 - 74.68
- Avg price
- 73.75
- Volume
- 542.28K
- Turnover
- 39.99M
- Turnover ratei
- 1.52%
- Volume ratioi
- 0.38
- Amplitudei
- 1.86%
- 52-week rangei
- 53.89 - 91.53
Valuation
- P/Ei
- -46.30
- P/E (TTM)i
- -68.79
- P/Bi
- 9.93
- EPSi
- -1.59
- Book value / shi
- 7.41
- Net profit
- -74.40M
- Net assets
- 346.73M
Share structure
- Market cap
- 3.44B
- Float capi
- 2.62B
- Shares out
- 46.79M
- Float sharesi
- 35.65M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2020-10-16
19.6% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+6.36M net over the window
Short interest
- Shares short
- 6.13M
- % of floati
- 13.10%
- Days to coveri
- 6.64
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Tarsus Pharmaceuticals (TARS)?
Tarsus Pharmaceuticals last traded at 73.61. The quote on this page refreshes every few seconds while US markets are open.
What is Tarsus Pharmaceuticals's market cap?
About 3.44B.
What is the P/E ratio of Tarsus Pharmaceuticals?
The trailing twelve-month P/E is -68.79. The Valuation tab shows it against the stock's own five-year range.
Does Tarsus Pharmaceuticals pay a dividend?
Tarsus Pharmaceuticals does not currently pay a regular dividend.
Is Tarsus Pharmaceuticals a buy according to analysts?
The consensus of 10 analysts is a Buy rating, with an average 12-month price target of 100.11, which implies 36.0% upside from the current price. This is not investment advice.
What is Tarsus Pharmaceuticals's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Tarsus Pharmaceuticals a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-08 07:01:30 · For reference only, not investment advice and not tailored to your situation.